PepT1 Drives Colitis-Linked Tumorigenesis, While t..

إنشاء مقالة جديدة

2 د

PepT1 Drives Colitis-Linked Tumorigenesis, While the Anti-Inflammatory Trisopeptide KPV Offers Therapeutic Protection in a Mouse Model | #over the counter peds

PepT1 Drives Colitis-Linked Tumorigenesis, While the Anti-Inflammatory Trisopeptide KPV Offers Therapeutic Protection i

The KPV peptide has emerged as a promising candidate in the field of oncology research, molchanovonews.

إعجاب

علق

2 د

PepT1 Drives Colitis-Linked Tumorigenesis, While the Anti-Inflammatory Tris­opeptide KPV Offers Therapeutic Protection i

اللغة

PepT1 Drives Colitis-Linked Tumorigenesis, While the Anti-Inflammatory Trisopeptide KPV Offers Therapeutic Protection i